Skip to main content
. 2016 Nov 8;7:1674. doi: 10.3389/fpls.2016.01674

Table 7.

Eighteen QTL identified on B genome by joint inclusive composite interval mapping (JICIM) for the CIMMYT NAM population.

QTL Trait name Chr. Pos. (cM) Left markera Right markera Length (cM) LOD PVE (%)b PB/DZc PB/CB PB/JC PB/KS PB/KB PB/KK PB/P76 PB/MU PB/KN Known gene/QTL region
q1BS-1 SR-OS2010 1BS 14 wPt-2389 wPt-9639 3.2 32.4 18.8 2.8 6.3 7.0 13.6 8.0 2.8 9.5 6.1 8.7 Validated by in silico mapping
YR-T2010 1BS 33 tPt-0325 wPt-8177 1.3 8.2 11.6 1.3 −0.6 −0.9 7.6 0.7 −11.0 3.1 0.3 2.3
SR-MS2010 1BS 38 wPt-668076 wPt-8682 1.5 53.0 27.9 2.5 7.0 6.1 15.8 19.4 9.3 8.2 −3.7 14.1
q1BS-2 YR-T2010 1BS 119 wPt-3266 wPt-0595 4.8 7.9 10.6 2.3 −1.8 0.7 −6.9 0.6 −9.8 3.1 −0.1 3.1
SR-MS2010 1BS 131 wPt-5740 wPt-7905 0.9 66.4 18.7 2.9 11.7 9.4 16.9 19.6 10.0 8.6 5.6 14.5
SR-OS2010 1BS 133 wPt-2075 wPt-744960 1.3 39.7 26.4 3.3 5.6 8.5 15.0 8.6 2.8 9.7 8.8 9.7
q1BL LR-2010 1BL 181 wPt-742017 wPt-2526 27.6 5.1 23.4 0.2 0.7 −3.1 −2.4 −13.0 Sr58/Yr29/Lr46
YR-T2010 1BL 185 wPt-742017 wPt-2526 27.6 9.7 31.6 2.1 −3.3 3.8 1.1 2.45 −24.9 2.9 0.8 −4.4
YR-T2010 1BL 200 wPt-0944 wPt-7066 12.3 9.0 9.6 0.8 −3.5 3.3 −5.1 1.7 −12.2 0.3 0.7 −4.0
q2BS-1 LR-2010 2BS 45 wPt-1964 wPt-8398 16.4 6.6 4.6 −0.2 −0.2 7.4 1.4 2.9 (Yu et al., 2011); Validated by in silico mapping
SR-MS2009 2BS 46 wPt-1964 wPt-8398 16.4 5.5 12.2 3.9 9.3 3.3 1.0 3.0
q2BS-2 LR-2010 2BS 127 wPt-1646 wPt-2327 11.5 5.5 7.5 0.3 −1.2 6.3 1.1 −4.9 Njau et al., 2013
YR-T2010 2BS 122 wPt-0489 wPt-1646 4.2 9.8 5.8 −5.4 −0.4 −1.8 −1.5 0.7 7.6 −0.1 3.2 −4.0
SR-MS2009 2BS 110 wPt-4125 wPt-0094 9.7 5.0 10.7 3.6 7.5 1.5 −0.1 −2.6
q2BL SR-MS2010 2BL 26 wPt-7829 wPt-2724 2.9 8.3 5.6 3.0 0.3 9.9 1.01 0.1 −3.9 2.1 −1.9 −1.8 (Kaur et al., 2009); Validated by in silico mapping
q3BS-1 YR-K2011 3BS 28 wPt-666139 wPt-3921 3.0 3.3 10.8 2.1 Sr2/Yr30/Lr27 (Kaur et al., 2009); Validated by in silico mapping
SR-MS2010 3BS 34 wPt-3921 wPt-800213 8.9 50.0 19.1 −5.5 1.5 9.0 10.1 13.2 12.1 12.0 14.5 11.3
LR-2010 3BS 35 wPt-3921 wPt-800213 8.9 4.3 3.8 0.0 0.2 6.1 −0.8 2.0
YR-K2010 3BS 38 wPt-800213 wPt-3609 1.8 5.4 8.4 −1.6 4.0 0.9 6.9 0.4
SR-MS2009 3BS 39 wPt-800213 wPt-3609 1.8 20.5 25.9 1.6 12.6 5.5 6.7 3.5
YR-T2010 3BS 39 wPt-800213 wPt-3609 1.8 9.4 2.3 2.7 1.7 0.3 5.3 4.4 −0.1 0.2 1.3 0.8
SR-MS2011 3BS 40 wPt-3761 wPt-2757 8.2 23.1 43.7 6.9 11.5
SR-OS2010 3BS 41 wPt-3761 wPt-2757 8.2 53.6 15.6 −5.1 1.3 8.0 11.6 11.2 14.0 9.6 10.5 10.7
q3BS-2 YR-T2010 3BS 99 wPt-743847 wPt-1081 6.2 5.9 1.8 −0.6 2.1 −3.2 1.4 3.4 2.3 2.2 1.2 −0.8 Njau et al., 2013
SR-MS2009 3BS 104 wPt-1081 wPt-9066 9.7 17.3 23.4 −0.9 9.8 5.0 7.8 3.5
SR-OS2010 3BS 107 wPt-1081 wPt-9066 9.7 29.3 10.3 0.9 −3.3 5.4 3.8 9.1 10.0 9.8 10.2 7.3
SR-MS2010 3BS 108 wPt-1081 wPt-9066 9.7 33.1 16.0 0.8 −0.8 4.25 1.92 9.8 9.8 11.5 14.1 10.6
YR-K2011 3BS 111 wPt-1081 wPt-9066 9.7 3.7 12.7 2.3
SR-MS2011 3BS 114 wPt-9066 wPt-740604 9.9 16.3 45.8 −1.3 10.9
q3BS-3 SR-OS2010 3BS 186 wPt-664393 wPt-9170 0.4 9.4 10.6 5.8 −0.1 4.2 10.6 −5.8 5.5 −1.0 1.3 1.7
q3BS-4 LR-2010 3BS 233 rPt-5396 wPt-5786 22.5 5.5 4.0 1.7 1.2 7.0 −0.8 −0.3 Yu et al., 2011
SR-MS2010 3BS 259 wPt-10142 wPt-7786 10.1 12.6 4.7 3.8 12.2 7.2 3.7 4.5 5.0 3.0 3.8 1.6
YR-T2010 3BS 261 wPt-4364 wPt-1940 0.6 15.9 14.0 1.4 −0.1 −0.4 3.6 −0.5 2.1 12.0 −0.5 0.5
q3BL-1 LR-2010 3BL 328 wPt-11278 wPt-0021 27.7 4.5 3.8 −0.4 −0.9 6.9 0.4 1.4
SR-OS2010 3BL 346 wPt-0021 wPt-9368 13.8 9.5 13.3 3.0 −6.6 9.9 9.58 1.2 −0.5 −0.9 1.5 2.6
q3BL-2 YR-K2010 3BL 384 wPt-6834 wPt-6131 3.6 5.4 11.2 3.9 −0.1 −0.6 8.0 −0.4
q4BS LR-2010 4BS 5 wPt-5559 wPt-4607 13.2 7.6 5.0 0.8 0.3 7.5 −0.5 2.9 Kaur et al., 2009
q5BL LR-2010 5BL 9 wPt-5896 wPt-1304 24.6 11.2 11.4 0.3 1.8 7.3 −2.6 −6.1 Kaur et al., 2009
SR-OS2010 5BL 20 wPt-5896 wPt-1304 24.6 5.4 17.7 1.3 4.3 −1.8 13.9 −2.2 −1.1 1.3 −2.1 −4.2
q6BS LR-2010 6BS 55 wPt-5971 wPt-2964 5.4 6.9 2.2 1.5 −0.3 4.9 −0.7 −1.5
q6BL SR-MS2010 6BL 6 wPt-2164 wPt-3168 4.2 6.6 6.7 2.6 −1.2 −4.2 8.4 −0.5 −0.9 2.5 2.1 4.4
SR-OS2010 6BL 9 wPt-2164 wPt-3168 4.2 6.1 11.6 0.9 −2.4 −2.2 12.1 −3.2 −1.8 1.5 1.3 1.0
YR-T2010 6BL 16 wPt-743099 wPt-8721 17.6 7.5 2.6 4.2 0.1 1.0 3.8 1.0 −3.4 1.7 3.9 2.5
SR-MS2009 6BL 21 wPt-743099 wPt-8721 17.6 3.8 8.0 −0.6 1.7 −1.2 5.6 1.4
q7BS SR-OS2010 7BS 24 wPt-0138 wPt-1541 26.2 9.5 31.1 0.0 −3.8 1.9 6.9 4.0 −0.8 −3.3 20.2 −1.4 Yu et al., 2011; Ghazvini et al., 2012
YR-T2010 7BS 29 wPt-0138 wPt-1541 26.2 5.3 3.7 −2.1 −0.6 0.8 −0.8 −2.5 −0.9 −4.9 7.1 −0.6
q7BL SR-OS2010 7BL 44 wPt-664219 wPt-0194 12.5 7.1 23.2 2.6 −3.5 −0.2 −3.5 −0.9 4.7 2.5 18.6 −0.8
LR-2011 7BL 45 wPt-664219 wPt-0194 12.5 4.2 17.1 −0.2 −0.7 3.7 4.9
YR-T2010 7BL 45 wPt-664219 wPt-0194 12.5 6.1 9.4 6.8 −0.9 −1.9 5.5 −0.5 5.6 0.1 −6.6 −0.7
a

Marker name in bold means this marker was also detected by single family mapping;

b

PVE, the phenotypic variance explained;

c

PB/DZ, PB/CB, PB/JC, PB/KS, PB/KB, PB/KK, PB/P76, PB/MU, and PB/KN were the RIL populations derived by PBW343 and Diniza, PBW343 and Crosbill, PBW343 and Juchi, PBW343 and Kenya Swara, PBW343 and Kingbird, PBW343 and Kenya Kudu, PBW343 and Pavon76, PBW343 and MUU, and PBW343 and Kenya Nyangumi, respectively. Underlined values were significant additive effects. Blanks means additive effects cannot be estimated, since there was no phenotypic data under the corresponding family. LOD threshold of 4.0 was used to report QTLs and determine common QTL across trials and populations. QTL having LOD score in the range of 3.0–4.0, and with pleiotropic effect with other QTL having LOD score higher than 4.0, were also reported.